Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/28380
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-08-26T06:20:19Z-
dc.date.available2022-08-26T06:20:19Z-
dc.date.issued2014-12-
dc.identifier.citationŞentürk, T. vd. (2014). "Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury". Atherosclerosis, 237(2), 760-766.en_US
dc.identifier.issn0021-9150-
dc.identifier.issn1879-1484-
dc.identifier.urihttps://doi.org/10.1016/j.atherosclerosis.2014.10.091-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0021915014015469-
dc.identifier.urihttp://hdl.handle.net/11452/28380-
dc.description.abstractObjective: Apoptosis is the early and predominant form of cell death in infarcted myocardia. The aim of the study was to investigate the effects of trimetazidine (TMZ) and N-acetylcysteine (NAC), used alone or in combination, on oxidative stress, infarct size, and ischemia-reperfusion (IR)-induced cardiomyocyte apoptosis in a rat model of myocardial IR. Methods and results: Myocardial IR was established by ligating an area under the left main coronary artery for 30 min followed by 3 h of reperfusion. Saline (1 ml/kg), NAC (50, 150 mg/kg), or TMZ (3, 5 mg/kg) was intravenously injected during the middle of the ischemic period. At the end of the reperfusion, blood samples were collected from the animals to measure serum M30 and M65 levels, which are markers of cell death, the S100b level, which is a marker of inflammation, and the malondialdehyde (MDA) level, which is a marker of oxidative stress. The infarct size was evaluated as the ratio of the infarct area to the risk area. Apoptotic activation was assessed by caspase-3 immunostaining and a TUNEL assay. TMZ and NAC, either alone or in combination, significantly reduced serum MDA levels, infarct area and apoptotic activity compared to those observed in saline group. Interestingly, the infarct area was more smaller in TMZ (3 and 5 mg/kg) injected groups (9.72 +/- 1.3% and 9.96 +/- 2.3%) than those observed in NAC (50 and 150 mg/kg) (16.1 +/- 2.5% and 19.1 +/- 2.14%) or TMZ (5 mg/kg)- NAC (150 mg/kg) combination groups (16.9 +/- 1.6%). However, the apoptotic activity was reduced more significantly in the combination of TMZ (5 mg/kg)-NAC (50 mg/kg) compared to TMZ-only group. Neither TMZ or NAC treatments nor the combination of the drugs significantly affected serum M30, M65 and S100B levels. Conclusion: Intravenous NAC and TMZ administration decreased oxidative stress, infarct area and apoptotic activity in a rat model of IR. Although the combination treatment was more effective in reducing the apoptotic activity than either treatment groups alone, TMZ treatment was more successful in reducing the infarct area than NAC or combination treatments. Present results suggest that, in addition to mechanical attempts to secure myocardial reperfusion, the use of TMZ and NAC may help to reduce IR injury.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTrimetazidineen_US
dc.subjectN-acetylcysteineen_US
dc.subjectMyocardiumen_US
dc.subjectReperfusion injuryen_US
dc.subjectApoptosisen_US
dc.subjectOxidative stressen_US
dc.subjectM30/M65en_US
dc.subjectFree-fatty-acidsen_US
dc.subjectInfarct sizeen_US
dc.subjectEndothelial-cellsen_US
dc.subjectHearten_US
dc.subjectNitroglycerinen_US
dc.subjectArrhythmiasen_US
dc.subjectActivationen_US
dc.subjectSevertiyen_US
dc.subjectDiseaseen_US
dc.subjectGlucoseen_US
dc.subjectCardiovascular system & cardiologyen_US
dc.titleEffective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injuryen_US
dc.typeArticleen_US
dc.identifier.wos000346066600086tr_TR
dc.identifier.scopus2-s2.0-84910630607tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Histoloji ve Embriyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı.tr_TR
dc.relation.bapUAP(T)-2009/6tr_TR
dc.identifier.startpage760tr_TR
dc.identifier.endpage766tr_TR
dc.identifier.volume237tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalAtherosclerosisen_US
dc.contributor.buuauthorŞentürk, Tunay-
dc.contributor.buuauthorÇavun, Sinan-
dc.contributor.buuauthorAvcı, Berrin-
dc.contributor.buuauthorYermezler, Aysun-
dc.contributor.buuauthorSerdar, Zehra-
dc.contributor.buuauthorSavcı, Vahide-
dc.contributor.researcheridABE-6685-2020tr_TR
dc.contributor.researcheridAAC-9702-2019tr_TR
dc.contributor.researcheridC-1517-2017tr_TR
dc.identifier.pubmed25463117tr_TR
dc.subject.wosCardiac & cardiovascular systemsen_US
dc.subject.wosPeripheral vascular diseaseen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ1en_US
dc.contributor.scopusid8342098300tr_TR
dc.contributor.scopusid6507468595tr_TR
dc.contributor.scopusid6603017388tr_TR
dc.contributor.scopusid55938747300tr_TR
dc.contributor.scopusid57222002284tr_TR
dc.contributor.scopusid6603687024tr_TR
dc.subject.scopusTrimetazidine; Heart Failure; Ketone Bodiesen_US
dc.subject.emtreeAcetylcysteineen_US
dc.subject.emtreeBiological markeren_US
dc.subject.emtreeCaspase 3en_US
dc.subject.emtreeCytokeratin 18en_US
dc.subject.emtreem65 proteinen_US
dc.subject.emtreeMalonaldehydeen_US
dc.subject.emtreeProtein S100Ben_US
dc.subject.emtreeSodium chlorideen_US
dc.subject.emtreeTrimetazidineen_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeAnimal cellen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeAnimal tissueen_US
dc.subject.emtreeApoptosisen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCoronary artery ligationen_US
dc.subject.emtreeCoronary risken_US
dc.subject.emtreeExperimental myocardial ischemiaen_US
dc.subject.emtreeHeart infarction preventionen_US
dc.subject.emtreeHeart infarction sizeen_US
dc.subject.emtreeHeart muscle cellen_US
dc.subject.emtreeHeart muscle reperfusionen_US
dc.subject.emtreeImmunohistochemistryen_US
dc.subject.emtreeInflammationen_US
dc.subject.emtreeLeft coronary arteryen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMonotherapyen_US
dc.subject.emtreeNick end labelingen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeOxidative stressen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeReperfusion injuryen_US
dc.subject.emtreeSerumen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.